January 22, 2009 / 6:02 PM / in 10 years

UPDATE 1-EU body recommends Teva's generic hepatitis C drug

(Adds details and background)

LONDON, Jan 22 (Reuters) - Israel’s Teva Pharmaceutical Industries Ltd TEVA.O has won backing from European regulators for its hepatitis C drug Ribavirin Teva, a generic version of Schering-Plough Corp’s SGP.N Rebetol.

Rebetol is an anti-viral drug often given in combination interferon therapy.

The European Medicines Agency said on Thursday it had adopted a positive opinion following a submission by Teva in May 2008. Recommendations from the agency are normally endorsed by the European Commission within a couple of months. (Reporting by Ben Hirschler)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below